Bérengère Sauvagnat

Author

Bérengère Sauvagnat

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

B. Sauvagnat, Berengere Sauvagnat, Bérengère Sauvagnat

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Université de Montpellier Centre National de la Recherche Scientifique United States Military Academy

About

Bérengère Sauvagnat is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, biomolecular engineering, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	8	8	439
2	Biomolecular Engineering	8	8	288
3	Natural Sciences	7	7	166
4	Medicine	6	6	802
5	Biochemistry	5	5	138

Bérengère Sauvagnat

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
An orally available non-nucleotide STING agonist with antitumor activity Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux, Science Antitumor ActivityImmunologyImmunoeditingImmunologic MechanismPharmacotherapy	2020	609
Nanoscale synthesis and affinity ranking Nathan J. Gesmundo, Bérengère Sauvagnat, Patrick J. Curran, Nature NanoparticlesEngineeringBottom-up SynthesisAffinity RankingNanotechnology	2018	201
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING Tony Siu, Michael D. Altman, Gretchen A. Baltus, ACS Medicinal Chemistry Letters	2018	163
Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges Tomi K. Sawyer, Anthony W. Partridge, Hung Yi Kristal Kaan, Bioorganic & Medicinal Chemistry EngineeringMedicineDrug DiscoveryPeptide EngineeringPeptide Therapeutic	2018	62
Poly(ethylene glycol) as solvent and polymer support in the microwave assisted parallel synthesis of aminoacid derivatives Bérengère Sauvagnat, Frédéric Lamaty, René Lazaro, Tetrahedron Letters Ethylene GlycolAminoacid DerivativesEngineeringPolymer ScienceOrganic Chemistry	2000	48
Structural characterization of nonactive site, TrkA-selective kinase inhibitors Hua-Poo Su, Keith Rickert, Christine Burlein, Proceedings of the National Academy of Sciences Nonactive SiteMedicinal ChemistryDrug TargetSignal TransductionTrka Selectivity	2016	48
Polyethylene glycol (PEG) as polymeric support and phase-transfer catalyst in the soluble polymer liquid phase synthesis of α-amino esters Bérengère Sauvagnat, Frédéric Lamaty, René Lazaro, Tetrahedron Letters Phase-transfer CatalystPolymer ReactionEngineeringPolymer ScienceBiomolecular Engineering	1998	39
Miniaturization of popular reactions from the medicinal chemists’ toolbox for ultrahigh-throughput experimentation Nathan J. Gesmundo, Kevin D. Dykstra, James L. Douthwaite, Nature Synthesis Medicinal ChemistryPharmaceutical ChemistryEngineeringNatural Product SynthesisMedicinal Chemists	2023	35
Integration of Affinity Selection–Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway Victoria Kutilek, Christine L. Andrews, Matthew Richards, SLAS DISCOVERY Drug TargetQuantitative PharmacologyBiological Mass SpectrometryChemical BiologySystems Pharmacology	2016	33
Soluble Polymer Supported Synthesis of α-Amino Acid Derivatives Bérengère Sauvagnat, Katarzyna Kulig, Frédéric Lamaty, Journal of Combinatorial Chemistry α-Amino Acid DerivativesEthylene GlycolSchiff BaseEngineeringEnantioselective Synthesis	2000	30

Page 1